Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): A retrospective analysis of 207 patients

Oral Oncology

Volumn 44, Issue 2, 2008, Pages 116-123

  Freier, Kolja ^a   Engel, Michael ^a   Lindel, Katja ^a   Flechtenmacher, Christa ^a   Mühling, Joachim ^a   Hassfeld, Stefan ^b   Hofele, Christof ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b KLINIKUM DORTMUND   (Germany)

Author keywords

Cisplatin; Head and neck surgery; Neoadjuvant radiochemotherapy; Oral squamous cell carcinoma

Indexed keywords

CISPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOTHERAPY; MOUTH CARCINOMA; NECK DISSECTION; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOADJUVANT THERAPY; NEOPLASM STAGING; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 38749138439     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.01.006     Document Type: Article

References (30)

1. Casiglia J., and Woo S.B. A comprehensive review of oral cancer. Gen Dent 49 1 (2001) 72-82
2. Funk G.F., Karnell L.H., Robinson R.A., Zhen W.K., Trask D.K., and Hoffman H.T. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24 2 (2002) 165-180
3. Silverman Jr. S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl (2001) 7S-11S
4. Shingaki S., Takada M., Sasai K., Bibi R., Kobayashi T., Nomura T., et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185 3 (2003) 278-284
5. Parsons J.T., Mendenhall W.M., Stringer S.P., Cassisi N.J., and Million R.R. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 39 1 (1997) 137-148
6. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 19 (2004) 1937-1944
7. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 9208 (2000) 949-955
8. Laramore G.E., Scott C.B., al-Sarraf M., Haselow R.E., Ervin T.J., Wheeler R., et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23 4 (1992) 705-713
9. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 19 (2004) 1945-1952
10. Aksu G., Karadeniz A., Saynak M., Fayda M., Kadehci Z., and Kocaelli H. Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients. Int J Oral Maxillofac Surg 35 6 (2006) 506-513
11. Kirita T., Ohgi K., Shimooka H., Yamanaka Y., Tatebayashi S., Yamamoto K., et al. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncol 35 6 (1999) 597-606
12. Wanebo H.J., Chougule P., Akerley III W.L., Koness R.J., McRae R., Nigri P., et al. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. Am J Surg 174 5 (1997) 518-522
13. Eckardt A., Wildfang I., and Karstens J.H. Simultaneous radiochemotherapy with taxol/carboplatin in advanced operable head-neck tumors. Preliminary results. Strahlenther Onkol 175 Suppl (1999) 311-313
14. Slotman G.J., Doolittle C.H., and Glicksman A.S. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival. Cancer 69 11 (1992) 2736-2743
15. Lindholm P., Valavaara R., Aitasalo K., Kulmala J., Laine J., Elomaa L., et al. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study. Radiother Oncol 78 2 (2006) 146-151
16. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 4 (2002) 195-215
17. Klug C., Wutzl A., Kermer C., Voracek M., Kornek G., Selzer E., et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 34 2 (2005) 143-148
18. Forastiere A., Goepfert H., Goffinet D., Hong K.W., Laramore G., Mittal B., et al. NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. Oncology (Williston Park) 12 7A (1998) 39-147
19. Porceddu S.V., Campbell B., Rischin D., Corry J., Weih L., Guerrieri M., et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 60 2 (2004) 365-373
20. Jen Y.M., Lin Y.C., Wang Y.B., and Wu D.M. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 3 (2006) 322-327
21. Jellema A.P., Doornaert P., Slotman B.J., Leemans C.R., and Langendijk J.A. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 2 (2005) 164-171
22. Schultze-Mosgau S., Grabenbauer G.G., Radespiel-Troger M., Wiltfang J., Ries J., Neukam F.W., et al. Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck 24 1 (2002) 42-51
23. Schultze-Mosgau S., Grabenbauer G.G., Wehrhan F., Radespiel-Troger M., Wiltfang J., Sauer R., et al. [Histomorphological structural changes of head and neck blood vessels after pre- or postoperative radiotherapy]. Strahlenther Onkol 178 6 (2002) 299-306
24. Hehr T., Classen J., Belka C., Welz S., Schafer J., Koitschev A., et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys 61 5 (2005) 1423-1431
25. Tsao A.S., Garden A.S., Kies M.S., Morrison W., Feng L., Lee J.J., et al. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol 24 25 (2006) 4163-4169
26. Hitt R., Lopez-Pousa A., Martinez-Trufero J., Escrig V., Carles J., Rizo A., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 34 (2005) 8636-8645
27. Grabenbauer G.G., Rodel C., Ernst-Stecken A., Brunner T., Hornung J., Kittel K., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only?. Radiother Oncol 66 1 (2003) 57-63
28. Thuerigen O., Schneeweiss A., Toedt G., Warnat P., Hahn M., Kramer H., et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 24 12 (2006) 1839-1845
29. Baselga J., Trigo J.M., Bourhis J., Tortochaux J., Cortes-Funes H., Hitt R., et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 23 24 (2005) 5568-5577
30. Schena M., Barone C., Birocco N., Dongiovanni D., Numico G., Colantonio I., et al. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study. Cancer Chemother Pharmacol 55 3 (2005) 271-276